Current Price Action and Market Context
As of 14 Aug 2026, Venus Remedies Ltd closed at ₹1,737.05, marking a robust day change of 4.83% from the previous close of ₹1,657.00. The stock traded within a range of ₹1,620.30 to ₹1,739.85 during the session, demonstrating strong intraday momentum. Despite being a micro-cap stock, its price action has been impressive, especially when compared to broader market benchmarks such as the Sensex.
Over the past week, Venus Remedies outperformed the Sensex significantly, delivering an 11.18% return against the Sensex’s decline of 1.11%. Year-to-date, the stock has surged 126.47%, dwarfing the Sensex’s negative 8.38% return. Even over longer horizons, Venus Remedies has delivered extraordinary gains, with a 10-year return of 1,930.45% compared to the Sensex’s 177.35%, underscoring its strong growth trajectory within the Pharmaceuticals & Biotechnology sector.
Technical Indicators: A Detailed Analysis
The technical landscape for Venus Remedies reveals a nuanced but increasingly positive picture. The Moving Average Convergence Divergence (MACD) indicator presents a mixed signal: while the weekly MACD remains mildly bearish, the monthly MACD has turned bullish. This divergence suggests that while short-term momentum may face some consolidation, the medium-term trend is strengthening.
The Relative Strength Index (RSI) currently shows no definitive signal on both weekly and monthly charts, indicating the stock is neither overbought nor oversold. This neutral RSI reading provides room for further upward movement without immediate risk of a reversal due to overextension.
Bollinger Bands on both weekly and monthly timeframes are bullish, signalling that price volatility is expanding on the upside and the stock is trending higher within its bands. This is a positive sign for momentum traders looking for continuation patterns.
Daily moving averages have turned bullish, reinforcing the short-term upward momentum. The stock price is comfortably above its key moving averages, which often act as dynamic support levels during pullbacks.
Additional Momentum Indicators
The Know Sure Thing (KST) oscillator is bullish on both weekly and monthly charts, confirming the strengthening momentum across multiple timeframes. This indicator’s positive readings often precede sustained price rallies, adding weight to the bullish thesis.
However, the Dow Theory presents a mixed view: mildly bearish on the weekly scale but bullish on the monthly. This suggests that while short-term price action may experience some volatility or minor corrections, the overall trend remains upward.
On-Balance Volume (OBV) is mildly bearish weekly but bullish monthly, indicating that while recent volume trends may show some selling pressure, the longer-term accumulation by investors remains intact. This volume pattern supports the notion of a healthy consolidation phase rather than a reversal.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Technical Trend Upgrade and Market Sentiment
Reflecting these technical improvements, Venus Remedies’ overall technical trend has been upgraded from mildly bullish to bullish. This upgrade aligns with the MarketsMOJO Mojo Score of 74.0, which corresponds to a Buy grade, an improvement from the previous Hold rating as of 13 Aug 2026. This upgrade signals increased confidence among technical analysts and market participants in the stock’s near-term prospects.
Such a shift is significant for a micro-cap stock in the Pharmaceuticals & Biotechnology sector, where volatility can be pronounced. The combination of bullish moving averages, positive KST readings, and supportive Bollinger Bands suggests that Venus Remedies is poised for further gains, provided broader market conditions remain favourable.
Price Levels and Historical Context
Venus Remedies currently trades at ₹1,737.05, below its 52-week high of ₹2,043.15 but well above its 52-week low of ₹423.70. This wide trading range over the past year highlights the stock’s volatility but also its capacity for substantial appreciation. The recent price momentum indicates a potential retest of the upper range, which could attract momentum-driven investors.
Comparing returns with the Sensex over various periods further emphasises the stock’s outperformance. For instance, the 1-year return of 260.65% vastly exceeds the Sensex’s negative 3.05%, while the 3-year return of 551.56% dwarfs the Sensex’s 19.53%. Such sustained outperformance is rare and underscores the stock’s strong fundamentals and technical appeal.
Curious about Venus Remedies Ltd from Pharmaceuticals & Biotechnology? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
Investor Takeaway and Outlook
For investors analysing Venus Remedies Ltd, the recent technical parameter changes provide a compelling case for a bullish outlook. The upgrade in technical trend, combined with a strong Mojo Score and Buy grade, suggests that the stock is gaining momentum and could continue to outperform its sector peers and the broader market.
While some weekly indicators like MACD and OBV show mild bearishness, these appear to be short-term consolidations within a larger bullish framework. The absence of RSI extremes further supports the potential for continued upward movement without immediate risk of a sharp correction.
Given the stock’s micro-cap status, investors should remain mindful of volatility and ensure appropriate risk management. However, the technical signals, supported by strong historical returns and fundamental strength, make Venus Remedies a noteworthy candidate for inclusion in growth-oriented portfolios within the Pharmaceuticals & Biotechnology sector.
Summary of Technical and Fundamental Strengths
Venus Remedies Ltd’s technical indicators collectively point to a positive momentum shift:
- Technical trend upgraded from mildly bullish to bullish
- Monthly MACD and Bollinger Bands bullish, weekly indicators mixed but improving
- Daily moving averages firmly bullish, supporting short-term price strength
- KST oscillator bullish across weekly and monthly timeframes
- Mojo Score of 74.0 with a Buy grade, upgraded from Hold
- Strong relative returns versus Sensex across multiple time horizons
These factors combine to present a robust technical and fundamental case for Venus Remedies as it navigates the evolving market landscape.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
